Open AccessCommentary: Use of biosimilars for retinal diseases in India: Challenges and concerns
Author(s) -
Aman Kumar,
Divya Agarwal,
Atul Kumar
Publication year - 2021
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/ijo.ijo_39_21
Subject(s) - medicine , aflibercept , ranibizumab , biosimilar , macular degeneration , ophthalmology , bevacizumab , pharmacology , retinal , pharmacodynamics , drug , macular edema , intensive care medicine , pharmacokinetics , surgery , chemotherapy